BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

SCIPHER MEDICINE CORPORATION — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

SCIPHER MEDICINE CORPORATION

via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)

2nd Quarter (Apr 1 - June 30) · 2023Posted Jul 19, 2023Filing document ↗LDA record ↗

Income$60Kfee reported

Client

Name: SCIPHER MEDICINE CORPORATION
Description: A precision immunology company matching each patient with their most effective therapy.
Location: Massachusetts · United States of America

Registrant

Firm: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
Description: Legislative and public affairs firm.
Location: Washington, District of Columbia, United States of America

Lobbying activities

2 issues

Health Issues
Lobbying related to CMS coverage determination.
LobbyistsARYANA KHALID · ADAM GOLDSTEIN · JESSICA GREENE
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Medicare/Medicaid
Lobbying related to CMS coverage determination.
LobbyistsARYANA KHALID · ADAM GOLDSTEIN · JESSICA GREENE
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.